Cargando…
AKR1B10 as a Potential Novel Serum Biomarker for Breast Cancer: A Pilot Study
BACKGROUND: Aldo-keto reductase 1B10 (AKR1B10) is a secretory protein that is upregulated in breast cancer. OBJECTIVE: This case-controlled pilot study evaluated the serum level of AKR1B10 in healthy women and patients with a localized or metastatic breast cancer. METHODS: AKR1B10 levels were measur...
Autores principales: | Cao, Zhe, Delfino, Kristin, Tiwari, Vivek, Wang, Xin, Hannan, Abdul, Zaidi, Fawwad, McClintock, Andrew, Robinson, Kathy, Zhu, Yun, Gao, John, Cao, Deliang, Rao, Krishna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908957/ https://www.ncbi.nlm.nih.gov/pubmed/35280770 http://dx.doi.org/10.3389/fonc.2022.727505 |
Ejemplares similares
-
Impact of cytotoxic chemotherapy on aldo-keto reductase family 1 member B10 expression
por: Robinson, Kathy, et al.
Publicado: (2023) -
AKR1B10 in gastrointestinal diseases
por: Shen, Yi, et al.
Publicado: (2015) -
AKR1B10 promotes breast cancer metastasis through integrin α5/δ-catenin mediated FAK/Src/Rac1 signaling pathway
por: Huang, Chenfei, et al.
Publicado: (2016) -
Isoniazid Induced Pure Red Blood Cell Aplasia
por: Azhar, Waqas, et al.
Publicado: (2020) -
Whistling Lipoma: Bronchial Obstruction Caused by a Lipoma
por: Azhar, Waqas, et al.
Publicado: (2020)